NCT02697448View on ClinicalTrials.gov

Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.

NACompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

June 30, 2023

Study Completion Date

February 28, 2024

Conditions

Atrial Fibrillation

Interventions

DRUG

propofol

Participant receives propofol as anesthetic for cardiac ablation.

DRUG

sevoflurane

Participant receives sevoflurane as anesthetic for cardiac ablations.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors

lead

Medical University of South Carolina

OTHER

NCT02697448 - Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation. | Biotech Hunter | Biotech Hunter